Cargando…

Assessing the Progression of Alzheimer’s Disease in Real-World Settings in Three European Countries

BACKGROUND: There exists considerable variation in disease progression rates among patients with Alzheimer’s disease (AD). OBJECTIVE: The primary objective of this observational study is to assess the progression of AD by characterizing cognitive, functional, and behavioral changes during the follow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lladó, Albert, Froelich, Lutz, Khandker, Rezaul K., Roset, Montserrat, Black, Christopher M., Lara, Nuria, Chekani, Farid, Ambegaonkar, Baishali M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075403/ https://www.ncbi.nlm.nih.gov/pubmed/33579841 http://dx.doi.org/10.3233/JAD-201172

Ejemplares similares

Quality of Life and Caregiver Burden of Alzheimer’s Disease Among Community Dwelling Patients in Europe: Variation by Disease Severity and Progression
por: Froelich, Lutz, et al.
Publicado: (2021)

Physician Perceptions about the Barriers to Prompt Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
por: Judge, Davneet, et al.
Publicado: (2019)

Physician Practice Patterns Associated with Diagnostic Evaluation of Patients with Suspected Mild Cognitive Impairment and Alzheimer's Disease
por: Judge, Davneet, et al.
Publicado: (2019)

Impact of Dementia-Related Behavioral Symptoms on Healthcare Resource Use and Caregiver Burden: Real-World Data from Europe and the United States
por: Chekani, Farid, et al.
Publicado: (2021)

Cardiometabolic outcomes among schizophrenia patients using antipsychotics: the impact of high weight gain risk vs low weight gain risk treatment
por: Khandker, Rezaul, et al.
Publicado: (2022)

Assessment of Real-Life Outcomes in Schizophrenia Patients according to Compliance
por: Qureshi, Zaina P., et al.
Publicado: (2020)

Economic outcomes associated with diagnosed behavioral symptoms among patients with dementia in the United States: a health care claims database analysis
por: Khandker, Rezaul Karim, et al.
Publicado: (2023)

Diagnosis of behavioral symptoms as a predictor of institutionalization among Medicaid patients with dementia
por: Khandker, Rezaul Karim, et al.
Publicado: (2023)

Non-professional caregiver burden is associated with the severity of patients’ cognitive impairment
por: Black, Christopher M., et al.
Publicado: (2018)

Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes
por: Khandker, Rezaul, et al.
Publicado: (2022)

Modeling acute care utilization: practical implications for insomnia patients
por: Chekani, Farid, et al.
Publicado: (2023)

The impact of antipsychotic adherence on acute care utilization
por: Perkins, Anthony J., et al.
Publicado: (2023)

Burden of hospitalizations and outpatient visits associated with moderate and severe acute graft-versus-host disease in Finland and Sweden: a real-world data study
por: Sabatelli, Lorenzo, et al.
Publicado: (2022)

Development and Temporal Validation of an Electronic Medical Record-Based Insomnia Prediction Model Using Data from a Statewide Health Information Exchange
por: Holler, Emma, et al.
Publicado: (2023)

Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer’s Disease Patients
por: Qureshi, Zaina P., et al.
Publicado: (2021)

Alzheimer’s Diagnosis: Real-World Physician Behavior Across Countries
por: Podhorna, Jana, et al.
Publicado: (2020)

Alzheimer’s Treatment: Real-World Physician Behavior Across Countries
por: Podhorna, Jana, et al.
Publicado: (2020)

Quantifying and Describing the Natural History and Costs of Alzheimer’s Disease and Effects of Hypothetical Interventions
por: Wimo, Anders, et al.
Publicado: (2020)

Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer’s Disease: A Structured Literature Review
por: Benca, Ruth, et al.
Publicado: (2022)

Impact of night-time symptoms in COPD: a real-world study in five European countries
por: Price, David, et al.
Publicado: (2013)

Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world
por: Gitt, Anselm K., et al.
Publicado: (2016)

Black-White Treatment Differences in Acute Myocardial Infarction
por: Mitchell, Janet B., et al.
Publicado: (1995)

Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries
por: Chakravarthy, Usha, et al.
Publicado: (2019)

Scala machine learning projects: build real-world machine learning and deep learning projects with Scala
por: Karim, Md Rezaul
Publicado: (2018)

Treatment patterns and outcomes among patients with small-cell lung cancer (SCLC) in Europe: a retrospective cohort study
por: Blackhall, Fiona, et al.
Publicado: (2023)

Current Diagnostic Pathways for Alzheimer’s Disease: A Cross-Sectional Real-World Study Across Six Countries
por: Roth, Sophie, et al.
Publicado: (2023)

Predictions of Alzheimer’s disease treatment and care costs in European countries
por: Cimler, Richard, et al.
Publicado: (2019)

Estimating the burden of illness related to genital warts in the Philippines: a nationally representative cross-sectional study
por: Buenconsejo, Lani, et al.
Publicado: (2019)

Variations in Medicare Access and Satisfaction by Health Status: 1991-93
por: Rosenbach, Margo L., et al.
Publicado: (1995)

Pharmacy and Medical Costs Associated With Switching Between Venlafaxine and SSRI Antidepressant Therapy for the Treatment of Major Depressive Disorder
por: Khandker, Rezaul K., et al.
Publicado: (2008)

Comparing the Pathway to Success in European Countries Competing in the Swimming World Championships
por: Yustres, Inmaculada, et al.
Publicado: (2019)

Java deep learning projects: implement 10 real-world deep learning applications using Deeplearning4j and open source APIs
por: Karim, Md Rezaul
Publicado: (2018)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
por: Pai, Ming-Chyi, et al.
Publicado: (2015)

Real-World Use of Symptomatic Treatments in Early Alzheimer’s Disease
por: Garcia, Maria João, et al.
Publicado: (2023)

Thalamic nuclei changes in early and late onset Alzheimer's disease
por: Forno, Gonzalo, et al.
Publicado: (2023)

Comparison of Visual Evoked Potentials and Retinal Nerve Fiber Layer Thickness in Alzheimer’s Disease
por: Kromer, Robert, et al.
Publicado: (2013)

Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries
por: von Moos, Roger, et al.
Publicado: (2017)

Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries
por: Oppelt, Katja A., et al.
Publicado: (2021)

Differential effects on out-of-hospital cardiac arrest of dihydropyridines: real-world data from population-based cohorts across two European countries
por: Eroglu, Talip E, et al.
Publicado: (2019)

Outcomes Following Adalimumab Bio-originator to Biosimilar Switch—A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries
por: Taylor, Peter C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_umq28mgqrhotb3v0s98atm7aib